Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection? A population-level view in the EHR-based RECOVER program

Mostrar otras versiones (1)

Long-term sequelae of severe acute respiratory coronavirus-2 (SARS-CoV-2) infection may include increased incidence of diabetes. Here we describe the temporal relationship between new type 2 diabetes and SARS-CoV-2 infection in a nationwide database. We found that while the proportion of newly diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Neha V., Yeh, Hsin-Chieh, Tronieri, Jena S., Stürmer, Til, Buse, John B., Reusch, Jane E., Johnson, Steven G., Wong, Rachel, Moffitt, Richard, Wilkins, Kenneth J., Harper, Jeremy, Bramante, Carolyn T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130848/
https://www.ncbi.nlm.nih.gov/pubmed/37125061
http://dx.doi.org/10.1017/cts.2023.34
Descripción
Sumario:Long-term sequelae of severe acute respiratory coronavirus-2 (SARS-CoV-2) infection may include increased incidence of diabetes. Here we describe the temporal relationship between new type 2 diabetes and SARS-CoV-2 infection in a nationwide database. We found that while the proportion of newly diagnosed type 2 diabetes increased during the acute period of SARS-CoV-2 infection, the mean proportion of new diabetes cases in the 6 months post-infection was about 83% lower than the 6 months preinfection. These results underscore the need for further investigation to understand the timing of new diabetes after COVID-19, etiology, screening, and treatment strategies.

Ejemplares similares